The Smads: transcriptional regulation and mouse models
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 11 (1-2), 37-48
- https://doi.org/10.1016/s1359-6101(99)00027-1
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Smad3 Inhibits Transforming Growth Factor-β and Activin Signaling by Competing with Smad4 for FAST-2 BindingJournal of Biological Chemistry, 1999
- Role of p300, a transcriptional coactivator, in signalling of TGF‐βGenes to Cells, 1998
- Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-βJournal of Biological Chemistry, 1998
- Human Smad3 and Smad4 Are Sequence-Specific Transcription ActivatorsMolecular Cell, 1998
- 1α,25-Dihydroxyvitamin D3Increases Transforming Growth Factor and Transforming Growth Factor Receptor Type I and II Synthesis in Human Bone CellsBiochemical and Biophysical Research Communications, 1997
- Inflammation and TGFβ1: Lessons from the TGFβ1 null mouseResearch in Immunology, 1997
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathwaysNature, 1996
- Serine Phosphorylation, Chromosomal Localization, and Transforming Growth Factor-β Signal Transduction by HumanJournal of Biological Chemistry, 1996
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- In vivo effects of human recombinant transforming growth factor β on bone turnover in normal miceJournal of Bone and Mineral Research, 1990